Johnson & Johnson (JNJ) Earns Hold Rating from Piper Jaffray Companies

& John. (JNJ)'s stock rose 6.85%. The institutional investor held 49,266 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $6.52 million, down from 52,120 at the end of the previous reported quarter. The company has a market capitalization of $366.18 billion, a PE ratio of 22.93 and a beta of 0.78. The stock decreased 0.02% or $0.01 on October 13, reaching $52.72. 4,106,625 shares of the company were exchanged.

The share price of Johnson & Johnson (NYSE:JNJ) was down -0.29% during the last trading session, with a day high of 137.42. It has underperformed by 4.16% the S&P500. (MET) stake by 10.54% reported in 2017Q2 SEC filing. Bollard Group LLC now owns 9,551 shares of the company's stock valued at $1,263,000 after buying an additional 459 shares during the last quarter. The company has market cap of $162.26 million. Solium Capital Inc. (TSE:SUM) has 0.00% since October 15, 2016 and is. It has outperformed by 80.12% the S&P500.

Since May 24, 2017, it had 0 insider purchases, and 2 insider sales for $230,155 activity. Therefore 43% are positive. ExOne had 8 analyst reports since August 12, 2015 according to SRatingsIntel. Benchmark maintained Marcus Corp (NYSE:MCS) rating on Friday, July 29. The stock of Johnson & Johnson (NYSE:JNJ) earned "Buy" rating by Cowen & Co on Thursday, August 24. RBC Capital Markets maintained it with "Buy" rating and $144.0 target in Friday, September 22 report. RBC Capital Markets maintained it with "Outperform" rating and $128 target in Wednesday, January 25 report. The company was initiated on Wednesday, September 9 by Imperial Capital. The firm has "Buy" rating by B. Riley & Co given on Wednesday, July 19.

Several other research firms have also issued reports on JNJ. Huntington Fincl Bank reported 1,000 shares or 0% of all its holdings.

More notable recent Citigroup Inc (NYSE:C) news were published by: which released: "Friday's Vital Data: AT&T Inc".

Hexavest Inc, which manages about $16.29B and $7.69 billion US Long portfolio, upped its stake in Alibaba Group Hldg Util (NYSE:BABA) by 60,123 shares to 265,975 shares, valued at $37.48M in 2017Q2, according to the filing.

Investors sentiment decreased to 1.04 in Q2 2017. Its up 0.04, from 1.04 in 2017Q1. It fall, as 11 investors sold MCS shares while 42 reduced holdings. 14 funds opened positions while 12 raised stakes. Monarch Prtn Asset Mngmt Llc owns 10,150 shares. Segall Bryant & Hamill Ltd Liability Corporation stated it has 1.42% of its portfolio in Johnson & Johnson (NYSE:JNJ). First Utd Bancorporation Trust holds 1.83% or 20,380 shares in its portfolio. About 4.11M shares traded. Florida-based Ifc Hldgs Fl has invested 0.02% in Marcus Corp (NYSE:MCS). Blue Chip Prns holds 3.04% or 65,937 shares. Athena Cap Ltd Com invested 0.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). Great West Life Assurance Can stated it has 27,404 shares. Overbrook Mgmt reported 64,498 shares. Vanguard Grp has 365,006 shares for 0% of their portfolio. Company insiders own 0.19% of the company's stock. 772.09 million shares or 1.67% less from 785.23 million shares in 2017Q1 were reported. Cullen Frost Bankers Inc holds 0.06% or 31,196 shares.

Based on the latest notes released to investors, 6 analysts have issued a rating of "buy", 5 analysts "outperform", 8 analysts "hold", 1 analysts "underperform" and 2 analysts "sell". Therefore 53% are positive. Contravisory Investment Management Inc.'s holdings in Johnson & Johnson were worth $7,194,000 at the end of the most recent reporting period. Jefferies maintained the stock with "Hold" rating in Tuesday, September 13 report. The company was maintained on Thursday, August 31 by BMO Capital Markets.

07/05/2017 - Johnson & Johnson had its "overweight" rating reiterated by analysts at Morgan Stanley.

Among 5 analysts covering ExOne (NASDAQ:XONE), 2 have Buy rating, 2 Sell and 1 Hold. The Oregon-based Northwest Inv Counselors Limited Co has invested 2.08% in Johnson & Johnson (NYSE:JNJ). Johnson & Johnson has a consensus rating of "Hold" and a consensus price target of $135.98. The rating was downgraded by Alembic on Friday, July 21 to "Underweight". The rating was initiated by Standpoint Research with "Sell" on Friday, May 20. The stock of L Brands Inc (NYSE:LB) earned "Outperform" rating by BMO Capital Markets on Wednesday, August 12.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on October, 17 before the open. The rating was downgraded by Goldman Sachs on Monday, January 9 to "Sell".

Investors sentiment decreased to 0.83 in Q2 2017. Its up 0.15, from 0.79 in 2017Q1.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. 81 funds opened positions while 307 raised stakes. Fisher Asset Management LLC raised its holdings in Johnson & Johnson by 3.7% in the 2nd quarter. Shares for $1.32 million were sold by Perez Beatriz R. IHT Wealth Management LLC increased its holdings in shares of Johnson & Johnson by 46.4% in the 2nd quarter. Cadinha And Co Lc holds 3.84% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 166,311 shares. 52,639 were accumulated by Bedrijfstakpensioenfonds Voor De Media Pno. Rowland & Counsel Adv holds 0% or 242,780 shares in its portfolio. Vigilant Capital Management Limited Com has 0.22% invested in Johnson & Johnson (NYSE:JNJ). Staley Advisers invested in 2.28% or 202,201 shares. Shelton Mgmt reported 0.38% in Johnson & Johnson (NYSE:JNJ). BlackRock Inc. boosted its holdings in Johnson & Johnson by 2.6% during the 2nd quarter. New England Private Wealth Advisors Limited Liability Corporation accumulated 5,566 shares. Axa has invested 1.18% in Johnson & Johnson (NYSE:JNJ). The company reported $1.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.79 by $0.04. After $1.83 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -2.19% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Like this



16 October 2017
Schroder Investment Management Group Cuts Stake in Texas Instruments Incorporated (NASDAQ:TXN)
In related news, insider Ellen Barker sold 15,000 shares of Texas Instruments stock in a transaction dated Monday, August 14th. Focusing about the past performance watch, the company stock escalated 2.45% in past week and accumulated 12.37% in one month.

15 October 2017
ConocoPhillips (NYSE:COP) Shares Sold by Barrett Asset Management LLC
The energy producer reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.16. The average Wall Street analyst rating for ConocoPhillips is Strong Buy, according to the average of 17 analyst scores.

15 October 2017
Joe Jonas, Sophie Turner Engaged 'She Said Yes'
After months of dating, Game of Thrones star Sophie Turner and boyfriend Joe Jonas broke some major relationship news on Sunday. Joe Jonas is heading down the aisle.

15 October 2017
No. 11 Miami escape Georgia Tech on late FG
Onside kicks to open the second half of a close game that then get returned for touchdowns by the other team are just stupid. Miami trailed Georgia Tech 14-13 at halftime and had to kick off to start the third quarter.

15 October 2017
Norris Perne & French LLP MI Purchases 12236 Shares of Starbucks Corporation (SBUX)
Also, Director Jorgen Vig Knudstorp bought 18,000 shares of the company's stock in a transaction dated Friday, August 4th. BidaskClub upgraded Starbucks Corporation from a "sell" rating to a "hold" rating in a report on Tuesday, August 1st.

15 October 2017
Next Weeks Broker Price Targets For Palo Alto Networks, Inc. (NYSE:PANW)
In other Palo Alto Networks news, insider Nir Zuk sold 146,000 shares of the stock in a transaction dated Tuesday, October 10th. With 134,000 avg volume, 9 days are for Scholastic Corporation (NASDAQ:SCHL)'s short sellers to cover SCHL's short positions.

15 October 2017
Mirati Therapeutics, Inc. (MRTX) Analysts See $-0.85 EPS
Mirati Therapeutics , Inc. (NASDAQ: MRTX ) has declined 76.51% since October 14, 2016 and is downtrending. Hedge funds and other institutional investors have recently made changes to their positions in the stock.

15 October 2017
Golden Knights put Fleury, Marchessault on injured reserve
Fleury, 32, won three Stanley Cups with the Penguins before being selected by the Golden Knights in the expansion draft. It is also worth noting that Fleury is now dealing with a concussion and will miss at least the next week of action.

15 October 2017
Time Warner (TWX) Given Daily Coverage Optimism Rating of 0.15
They expect $1.59 EPS, down 13.11% or $0.24 from last year's $1.83 per share. 697,828 were accumulated by Saratoga Rech & Mngmt. Cowen and Company reiterated a "hold" rating and set a $107.50 target price on shares of Time Warner in a report on Thursday.

15 October 2017
Boston Scientific Corporation (BSX) Stake Increased by Janus Henderson Group PLC
TRADEMARK VIOLATION NOTICE: This news story was originally published by Equities Focus and is the property of of Equities Focus. Tributary Capital Management Llc decreased Boston Scientific Corp Com ( BSX ) stake by 68.95% reported in 2017Q2 SEC filing.